Wiley Blackwell

SHERPA: Unknown

People

  1. Ladanyi
    Ladanyi
  2. Hakimi
    Hakimi
  3. Solit
    Solit
  4. Berger
    Berger
  5. Russo
    Russo
  6. Coleman
    Coleman
  7. D'Angelica
    D'Angelica
  8. Jarnagin
    Jarnagin
  9. Kingham
    Kingham
  10. Motzer
    Motzer

Groups

  1. Human Oncology and Pathogenesis Program (149)
  2. GSK Faculty (133)
  3. Department of Medicine (98)
  4. Department of Pathology and Laboratory Medicine (89)
  5. Solid Tumor Oncology Division (80)
  6. Surgery (67)
  7. Survivorship Research (49)
  8. Tow Center for Developmental Oncology (TCDO) (49)
  9. Sloan Kettering Institute Postdocs (47)
  10. Genitourinary Oncology Service (43)
Search Within
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (105)
  2. Meeting Abstract (36)
  3. Review (7)
  4. Guidelines (1)
Groups
  1. Human Oncology and Pathogenesis Program (149)
  2. GSK Faculty (133)
  3. Department of Medicine (98)
  4. Department of Pathology and Laboratory Medicine (89)
  5. Solid Tumor Oncology Division (80)
  6. Surgery (67)

More Groups

People
  1. Marc Ladanyi (31)
  2. Abraham Hakimi (25)
  3. David Solit (25)
  4. Michael Berger (22)
  5. Paul Russo (18)
  6. Jonathan Coleman (17)

More People

Years
  1. 2025 (2)
  2. 2024 (8)
  3. 2023 (9)
  4. 2022 (12)
  5. 2021 (9)
  6. 2020 (14)

More Years

Publications
  1. Cancer (40)
  2. Journal of Pathology (24)
  3. BJU International (21)
  4. Journal of Surgical Oncology (10)
  5. Histopathology (8)
  6. Hematological Oncology (6)

More Publications

Results (149)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of everolimus in metastatic urothelial cancer
    Journal Article

    Milowsky, M. I.; Iyer, G.; Regazzi, A. M.; Al-Ahmadie, H.; Gerst, S. R.; Ostrovnaya, I.; Gellert, L. L.; Kaplan, R.; Garcia-Grossman, I. R.; Pendse, D.; more...
    BJU International (2013)

    Fulltext@MSK | Save
  • Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein
    Journal Article

    Kobos, R.; Nagai, M.; Tsuda, M.; Merl, M. Y.; Saito, T.; Lae, M.; Mo, Q.; Olshen, A.; Lianoglou, S.; Leslie, C.; more...
    Journal of Pathology (2013)

    Fulltext@MSK | Save
  • TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS
    Journal Article

    Deplus, R.; Delatte, B.; Schwinn, M. K.; Defrance, M.; Mendez, J.; Murphy, N.; Dawson, M. A.; Volkmar, M.; Putmans, P.; Calonne, E.; more...
    EMBO Journal (2013)

    Fulltext@MSK | Save
  • BRAF Mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer
    Journal Article

    Grisham, R. N.; Iyer, G.; Garg, K.; DeLair, D.; Hyman, D. M.; Zhou, Q.; Iasonos, A.; Berger, M. F.; Dao, F.; Spriggs, D. R.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • MLH1 -silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapes
    Journal Article

    Donehower, L. A.; Creighton, C. J.; Schultz, N.; Shinbrot, E.; Chang, K.; Gunaratne, P. H.; Muzny, D.; Sander, C.; Hamilton, S. R.; Gibbs, R. A.; more...
    Journal of Pathology (2013)

    Fulltext@MSK | Save
  • Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas
    Journal Article

    Johnson, M. L.; Sima, C. S.; Chaft, J.; Paik, P. K.; Pao, W.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
    Cancer (2013)

    Fulltext@MSK | Save
  • Next-generation sequencing reveals genomic determinants of long-term response to mTOR inhibitors in patients with advanced RCC
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Brannon, A. R.; Scott, S.; Takeda, S.; Liu, H.; Chen, Y.; Motzer, R. J.; Berger, M. F.; Hsieh, J. J.
    BJU International (2012)

    Fulltext@MSK | Save
  • Preexisting hypertension is associated with advanced tumor stage but improved cancer specific survival in clear cell renal cell carcinoma
    Meeting Abstract

    Hakimi, A. A.; Fiegoli, B.; Zabor, E. C.; Bernstein, M.; Furberg-Barnes, A. H.; Russo, P.
    BJU International (2012)

    Fulltext@MSK | Save
  • Tumor suppressor screens of 3p chromatin modulators link BAP1 mutations to poor clinical outcomes in clear cell renal cell carcinoma
    Meeting Abstract

    Hakimi, A. A.; Chen, Y. B.; Wren, J.; Ostrovnaya, I.; Gonen, M.; Abdel-Wahab, O.; Heguy, A.; Liu, H.; Takeda, S.; Tickoo, S. K.; more...
    BJU International (2012)

    Fulltext@MSK | Save
  • Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas
    Journal Article

    Paik, P. K.; Johnson, M. L.; D'Angelo, S. P.; Sima, C. S.; Ang, D.; Dogan, S.; Miller, V. A.; Ladanyi, M.; Kris, M. G.; Riely, G. J.
    Cancer (2012)

    Fulltext@MSK | Save